as 11-15-2024 3:41pm EST
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.
Founded: | 2016 | Country: | United States |
Employees: | N/A | City: | AUSTIN |
Market Cap: | 1.5B | IPO Year: | 2021 |
Target Price: | $5.02 | AVG Volume (30 days): | 5.2M |
Analyst Decision: | Hold | Number of Analysts: | 17 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.94 | EPS Growth: | N/A |
52 Week Low/High: | $1.57 - $13.76 | Next Earning Date: | 11-07-2024 |
Revenue: | $5,594,117,000 | Revenue Growth: | 54.10% |
Revenue Growth (this year): | 41.07% | Revenue Growth (next year): | 22.27% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Sell Steven | AGL | CEO & President | Sep 12 '24 | Buy | $3.36 | 20,000 | $67,188.00 | 67,590 |
AGL Breaking Stock News: Dive into AGL Ticker-Specific Updates for Smart Investing
Business Wire
5 days ago
GuruFocus.com
9 days ago
Zacks
9 days ago
Zacks
9 days ago
Business Wire
9 days ago
GuruFocus.com
11 days ago
Business Wire
11 days ago
Business Wire
a month ago
The information presented on this page, "AGL agilon health inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.